InvestorsHub Logo
Followers 38
Posts 324
Boards Moderated 0
Alias Born 10/09/2013

Re: 123tom post# 12844

Friday, 02/05/2016 3:06:46 PM

Friday, February 05, 2016 3:06:46 PM

Post# of 34618
Thanks 123...but I'm really interested to know about the two competing sciences not chart comparison [in my prior post] TPIV and IMGN"s Ovarian/her2Nue collaboration with Merck and Keytruda combination.

Should we be concerned?

RK or anyone else would be appreciated.

BLU
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent MRKR News